Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 1107261 HOUSTON, TX
Back to BDTX Full portfolio

Position in BDTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,464,152
-$76,854 QoQ
Shares Held
791,434
+9.4% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#13
of 96 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BDTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. BDTX ranks #12 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in BDTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,464,152 791,434
2026-03-31 $1,541,006 723,477
2025-12-31 $421,119 173,300
2025-09-30 $372,557 98,300
2025-06-30 $243,784 98,300
2025-03-31 $113,305 73,100
2024-12-31 $309,444 144,600
2024-09-30 $649,020 149,200
2024-06-30 $806,180 173,000
2024-03-31 $877,110 173,000
2023-12-31 $539,520 192,000
2023-09-30 $363,055 126,500
2023-06-30 $378,750 75,000
2023-03-31 $141,750 75,000
2022-12-31 $225,000 125,000
2022-09-30 $211,250 125,000
2022-06-30 $160,392 65,200
2022-03-31 $213,844 77,200